// App-Quantinova.ai

2691431 : Real-world outcomes of Aflibercept treatment for chronic diabetic macular edema in Bevacizumab non-responders in a Canadian setting

Researchers

Presenter

  • Ali Salimi

Principal Investigators

  • Natalia Vila

  • Michael Kapusta

Medical Centers

  • Ophthalmology, Montreal Jewish General Hospital, Montreal, Quebec, Canada

  • RI-MUHC, McGill University, Montreal, Quebec, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Aflibercept

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved